The merger which was announced on 9 December and will close in January 2021, will see Stratasys expand on its leadership in the fast-growing mass production parts segment with the addition of the proprietary next-generation photopolymer platform – Programmable PhotoPolymerization (P3) technology from Origin to its portfolio.
Origin’s tech is projected to become an important growth engine for Stratasys, adding up to $200 million incremental annual revenue within five years. Stratasys is also poised to fortify their position in polymers and production applications of 3D printing in industries such as dental, medical, tooling, and select industrial, defense, and consumer goods segments.
When combined with Origin’s extensive materials ecosystem and our industry-leading go-to-market capabilities, we believe we will be able to capture a wide range of in-demand production applications on a global scale.Yoav Zeif, Stratasys CEO
An advancement on Digital Light Processing (DLP) principles, Origin’s P3 technology, cures liquid photopolymer resin with light. The technology enables customers to build parts with industry-leading accuracy, consistency, size and detail, while using a wide range of commercial-grade, durable resins from Henkel, BASF, and DSM.
Origin’s technology was especially highlighted during the onset of the COVID-19 pandemic earlier this year for their fit for production applications, with the production of hundreds of thousands of clinically validated nasopharyngeal swabs, thousands of PPE face shields, and ventilator splitters for hospitals.
Origin currently has annual revenue in the “single-digit” millions but Zeif expects to crank that up substantially in the second half of 2021 as Stratasys’s resellers begin marketing Origin’s machines to a larger customer base.